Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection

被引:0
|
作者
de Almeida Ponde, Roberio Amorim [1 ,2 ]
机构
[1] Coordenacao Anal & Pesquisas CAP, Gerencia Vigilancia Epidemiol Doencas Transmissive, Secretaria Estado Saude SES, Superintendencia Vigilancia Saude SUVISA GO, Goiania, Go, Brazil
[2] Rua 136 Qd F44 Lt 22-24 Ed Cesar Sebba Setor Sul, BR-74093250 Goiania, Go, Brazil
关键词
HBV markers; Sensitivity and specificity; Clinical classification; Case definition; Epidemiological surveillance; ACUTE EXACERBATION; BLOOD-DONORS; UNDERLYING MECHANISMS; VIRAL-HEPATITIS; HBSAG ASSAYS; SERUM HBSAG; DIAGNOSIS; MUTATIONS; DNA; DIFFERENTIATION;
D O I
10.1007/s11033-025-10278-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis B virus surface antigen (HBsAg), IgM and IgG antibodies to hepatitis B virus core antigen (anti-HBcIgM and anti-HBcIgG) comprise serological markers of hepatitis B virus (HBV) infection of great importance in the epidemiological surveillance of hepatitis B, since they have been routinely considered for classifying the acute and chronic clinical forms of HBV infection. This classification is established according to the expression and dynamics of these markers in the infected person's bloodstream, which serves as the basis for the differential diagnosis between the two clinical entities. However, in certain circumstances, both acute and chronic infection, the detection of these markers may not occur in the bloodstream, favoring the occurrence of atypical serological profiles of infection, and compromising the correct infection clinical classification. In addition, the complex and varied nature of hepatitis B serological profiles may compromise the health professional's ability to analyze the case and, thus, correctly classify the infection's clinical form. Since the expression of these markers in the bloodstream occurs dynamically, with consequent changes in the patient's serological profile as he progresses towards recovery or chronicity, the diagnosis of acute or chronic infection may also be compromised, if it is established based on the collection of a single sample and without knowing the patient's clinical history and their epidemiological antecedents. This manuscript addresses the sensitivity and specificity of HBsAg, anti-HBcIgM, and anti-HBcIgG serological markers detection in the clinical classification of HBV infection and in the epidemiological surveillance of hepatitis B. This review is covering the clinical and epidemiological interpretations of the markers in and of themselves, not in reference to any specific assays.
引用
收藏
页数:16
相关论文
共 50 条
  • [11] Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors
    Seo, Dong Hee
    Whang, Dong Hee
    Song, Eun Young
    Kim, Hyun Soo
    Park, Quehn
    TRANSFUSION, 2011, 51 (08) : 1840 - 1846
  • [12] Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
    Matsumoto, Akihiro
    Tanaka, Eiji
    Morita, Susumu
    Yoshizawa, Kaname
    Umemura, Takeji
    Joshita, Satoru
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (09) : 1006 - 1013
  • [13] Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations
    Baruti, Kabo
    Choga, Wonderful T.
    Phinius, Bonolo B.
    Phakedi, Basetsana
    Bhebhe, Lynnette
    Mpebe, Gorata G. A.
    Motshosi, Patience C.
    Ratsoma, Tsholofelo
    Moyo, Sikhulile
    Jongman, Mosimanegape
    Anderson, Motswedi
    Gaseitsiwe, Simani
    GENES, 2024, 15 (08)
  • [14] Clinical implications of the titer of serum hepatitis B surface antigen during the natural history of hepatitis B virus infection
    Suh, Sang Jun
    Bae, Song-I
    Kim, Ji Hoon
    Kang, Keunhee
    Yeon, Jong Eun
    Byun, Kwan Soo
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (01) : 117 - 123
  • [15] Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma
    Suzuki, Yuichiro
    Maekawa, Shinya
    Komatsu, Nobutoshi
    Sato, Mitsuaki
    Tatsumi, Akihisa
    Miura, Mika
    Matsuda, Shuya
    Muraoka, Masaru
    Nakakuki, Natsuko
    Shindo, Hiroko
    Amemiya, Fumitake
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Nakayama, Yasuhiro
    Yamaguchi, Tatsuya
    Inoue, Taisuke
    Sato, Tadashi
    Sakamoto, Minoru
    Yamashita, Atsuya
    Moriishi, Kohji
    Enomoto, Nobuyuki
    HEPATOLOGY RESEARCH, 2019, 49 (01) : 51 - 63
  • [16] Clinical significance of hepatitis B virus-DNA in hepatocellular carcinoma negative for hepatitis B virus surface antigen
    Tateiwa, Shinpei
    Yano, Yoshihiko
    Seo, Yasushi
    Miki, Akira
    Yuuki, Kawano
    Azuma, Takeshi
    Hayashi, Yoshitake
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (02) : 343 - 346
  • [17] Hepatitis B virus core-related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report
    Yokoyama, Keiji
    Yamauchi, Eri
    Uchida, Yotaro
    Kitaguchi, Takanori
    Fukuda, Hiromi
    Yamauchi, Ryo
    Tsuchiya, Naoaki
    Umeda, Kaoru
    Takata, Kazuhide
    Tanaka, Takashi
    Inomata, Shinjiro
    Morihara, Daisuke
    Takeyama, Yasuaki
    Shakado, Satoshi
    Sakisaka, Shotaro
    Hirai, Fumihito
    CLINICAL CASE REPORTS, 2020, 8 (12): : 3031 - 3036
  • [18] Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen
    Zhang, R.
    Wang, L.
    Li, J.
    TRANSFUSION MEDICINE, 2010, 20 (05) : 322 - 328
  • [19] Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors
    Muselmani, W.
    Habbal, W.
    Monem, F.
    TRANSFUSION MEDICINE, 2013, 23 (04) : 265 - 268
  • [20] Clinical and virological characteristics of coexistent hepatitis B surface antigen and antibody in treatment-naive children with chronic hepatitis B virus infection
    Xu, Yi
    Li, Shuangjie
    Ouyang, Wenxian
    Yao, Zhenzhen
    Lai, Xin
    Gu, Yingping
    Yang, Meng
    Ye, Ling
    Li, Sisi
    Peng, Songxu
    FRONTIERS IN PUBLIC HEALTH, 2024, 12